Late and chronic Lyme disease

Medical Clinics of North America

Volumn 86, Issue 2, 2002, Pages 341-349

  Donta, Sam T ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MINOCYCLINE; PENICILLIN G; TETRACYCLINE;

BORRELIA BURGDORFERI; CHRONIC DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; HUMAN; LABORATORY DIAGNOSIS; LYME DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOM;

EID: 0036223744     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00090-7     Document Type: Review

References (33)

1. Lyme disease: An infectious and postinfectious syndrome
2. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology
3. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin
4. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease
5. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme disease
6. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis, and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome
7. Lyme disease: A clinical challenge
8. Tetracycline therapy of chronic Lyme disease
9. Reactivation of latent Lyme disease
10. Treatment of chronic Lyme disease with macrolide antibiotics
11. Reactivation of Lyme disease following OspA vaccine
12. The existence of chronic Lyme disease
13. Western blotting in the serodiagnosis of Lyme disease
14. Lyme disease: A neuropsychiatric illness
15. Early Lyme disease: A flu-like illness without erythema migrans
16. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum
17. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro
18. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis
19. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease
20. In vitro susceptibilities of Borrelia burgdorferi to 11 antimicrobial agents
21. Azithromycin compared with amoxicillin in the treatment of erythema migrans: A double blind, randomized, controlled trial
22. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: The Coxiella burnetii paradigm
23. Chronic infections as a common etiology for many patients with chronic fatigue syndrome, fibromyalgia, and Gulf War Illness
24. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease
25. In vitro and in vivo susceptibility of Borrelia burgdorferi
26. Pathogenesis of Lyme neuroborreliosis in the Rhesus monkey: The early disseminated and chronic phases of disease in the peripheral nervous system
27. Long-term outcomes of persons with Lyme disease
28. The long-term clinical outcomes of Lyme disease
29. Lyme disease
30. Erythema chronicum migrans and Lyme arthritis: The enlarging clinical spectrum
31. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period
32. Practice guidelines for the treatment of Lyme disease
33. Physician preferences in the diagnosis and treatment of Lyme disease in the U.S.